VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $322,963 | -34.4% | 74,760 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $492,668 | -2.9% | 74,760 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $507,620 | +29.7% | 74,760 | +41.2% | 0.00% | 0.0% |
| Q4 2022 | $391,374 | +31.3% | 52,960 | +75.6% | 0.00% | 0.0% |
| Q3 2022 | $298,000 | -9.4% | 30,160 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $329,000 | -3.5% | 30,160 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $341,000 | -27.9% | 30,160 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $473,000 | -48.2% | 30,160 | -43.4% | 0.00% | -50.0% |
| Q3 2021 | $914,000 | -20.2% | 53,300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,146,000 | +43.1% | 53,300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $801,000 | +14.4% | 53,300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $700,000 | +35.9% | 53,300 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $515,000 | -15.6% | 53,300 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $610,000 | +10.5% | 53,300 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $552,000 | -28.1% | 53,300 | +13.9% | 0.00% | 0.0% |
| Q4 2019 | $768,000 | – | 46,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |